{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:10:45Z","timestamp":1787735445119,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijrobp.2015.11.025","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T03:18:01Z","timestamp":1449026281000},"page":"605-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer"],"prefix":"10.1016","volume":"94","author":[{"given":"Stephen L.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pretesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Bynum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Palta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Oleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.11.025_bib1","series-title":"Cancer statistics, vol. 2014","year":"2014"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib2","first-page":"289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0360-3016(03)00784-3","article-title":"Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer","volume":"58","author":"Kupelian","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib6","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib7","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":"Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib8","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pt3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib11","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1200\/JCO.2006.09.6495","article-title":"Predominant treatment failure in postprostatectomy patients is local: Analysis of patterns of treatment failure in SWOG 8794","volume":"25","author":"Swanson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib12","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","article-title":"Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(01)01650-9","article-title":"Is the alpha\/beta ratio for prostate cancer low?","volume":"51","author":"D'Souza","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer?","volume":"56","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate cancer alpha\/beta ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.02.049","article-title":"Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer","volume":"84","author":"Arcangeli","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijrobp.2014.01.015","article-title":"Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: Results from a randomized trial","volume":"88","author":"Hoffman","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib19","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib20","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2013.51.1972","article-title":"Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer","volume":"31","author":"Pollack","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHIP randomised controlled trial","volume":"13","author":"Dearnaley","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2015.10.049","article-title":"NRG oncology RTOG 0415: A randomized phase III non-inferiority study comparing 2 fractionation schedules in patients with low risk prostate cancer","volume":"94","author":"Lee","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib23","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/cncr.25824","article-title":"Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence","volume":"117","author":"Kruser","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib24","first-page":"2785","article-title":"Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial","volume":"33","author":"Massaccesi","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of rtog consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clon.2007.02.007","article-title":"Is the alpha\/beta value for prostate tumours low enough to be safely used in clinical trials?","volume":"19","author":"Dasu","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2010.32.2701","volume":"29","author":"Shipley","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2011.08.006","article-title":"Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy","volume":"60","author":"Goenka","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-410X.2009.08684.x","article-title":"Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: Results from the shared equal access regional cancer hospital database","volume":"105","author":"Moreira","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2008.05.006","article-title":"Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genitourinary Group","volume":"88","author":"Sidhom","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","article-title":"Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)","volume":"366","author":"Bolla","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib32","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.eururo.2014.06.012","article-title":"Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: A single-institution analysis of 1176 patients","volume":"66","author":"Cozzarini","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2007.07.017","article-title":"Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group","volume":"84","author":"Poortmans","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.11.025_bib34","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2007.04.068","article-title":"Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy","volume":"69","author":"Wiltshire","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615267636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615267636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:55:53Z","timestamp":1537170953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615267636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0360301615267636"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.11.025","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}